Velocity’s New Smyrna Beach research site was founded in 2010 as Riverside Clinical Research, and acquired by Velocity in 2021. The New Smyrna Beach (NSB) site has a wide range of expertise including vaccines, orthopedic, gastroenterology, neurology trials, and more. Velocity NSB staff prides themselves on being efficient and quality driven. This leads to a great experience for all those involved in clinical trials.
The site is conveniently located along a major highway on Florida’s east coast. Ample parking is available for patients, as well as patient amenities such as theatre room on site. The site is 3 miles away from the local hospital.
All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The New Smyrna Beach team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.